Publication | Closed Access

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

OncologyGastrointestinal OncologyCancer ManagementClinical TrialsColorectal CancerMetastatic Colorectal CancerPharmacotherapyAsian PatientsMedicineRadiation OncologyHealth Sciences